Encision signs supply agreement with J&J’s Auris Health
Encision today announced that it has entered a supply agreement with Johnson & Johnson (NYSE:JNJ) robotic surgery subsidiary Auris […]
Encision today announced that it has entered a supply agreement with Johnson & Johnson (NYSE:JNJ) robotic surgery subsidiary Auris […]
Stryker (NYSE: SYK) today announced that it has launched its T2 Alpha femur retrograde nailing system. […]
Researchers at MIT and Shanghai Jiao Tong University created an inexpensive robotic hand intended for […]
Shoulder Innovations this week announced that it has received FDA 510(k) clearance for its InSet […]
Nordson Corporation today announced that it has signed a definitive agreement to acquire Spectris’s NDC Technologies […]
ResusRight raised nearly $800,000 to launch a newborn resuscitation training system, and to develop a resuscitation device prototype for use in the clinical setting at birth.
Rockley Photonics recently went public through a merger with a special-purpose acquisition company called SC Health […]
The EMPOWER trial will evaluate Cardiac Dimensions’ Carillon Mitral Contour System and look at about 300 patients at 75 sites.
Bill Gates-backed Vicarious Surgical, which is set to go public in a SPAC deal, hopes to reach $1 billion in revenue by 2027 as it takes on the goliath of surgical robots.
Pulse Biosciences (NSDQ:PLSE) announced today that it appointed Mitchell E. Levinson to its newly created chief […]
Auctus Surgical has received US Food and Drug Administration (FDA) breakthrough device designation for its […]
Johnson & Johnson’s (NYSE:JNJ) DePuy Synthes this week announced that it has launched its Inhance shoulder system. DePuy […]
Stryker has announced the launch of SurgiCount+ safety-sponge system—its next-generation surgical sponge counting technology. SurgiCount+ […]
“I have tried several devices in the last 10 or 20 years, but I think […]
Medtronic’s Micra pacemakers are one-tenth the size of what was previously out there. How the […]
A total of 10 patients will be enrolled into the feasibility study, which, if successful, will lead to a larger erectile dysfunction study involving around 50 patients.
MedAlliance announced today that it enrolled the first patient in an erectile dysfunction (ED) feasibility study […]
Strata Skin Sciences (NSDQ:SSKN) announced that it acquired the Pharos dermatology business from Ra Medical (NYSE:RMED). Horsham, Pa.-based […]
Zimmer Biomet (NYSE:ZBH) today announced that it received FDA 510(k) clearance for its Rosa Hip system […]
Abiomed (NSDQ:ABMD) today announced that the FDA has granted breakthrough device designation for its Impella ECP […]
Swing Therapeutics has emerged from stealth mode with the achievement of several key business and regulatory milestones.
Freudenberg Medical recently announced that it has increased its catheter sensor integration capabilities. The expanded capabilities […]
Insightec has announced that Seoul National University Hospital (SNUH) is installing the company’s Exablate Neuro […]
ResMed (NYSE:RMD) has debuted its next-generation positive airway pressure (PAP) device, AirSense 11. San Diego–based ResMed’s […]
Abbott today announced that it has received FDA approval for its Amplatzer Amulet device to […]
Able Medical Devices recently announced that its Mach screw clip system has received FDA 510(k) […]
Globus Medical recently announced that it has received FDA 510(k) clearance for its Excelsius3D intelligent […]
Aerin Medical today touted one-year results from a trial evaluating the safety and efficacy of its […]
Sinomed announced today that it completed the first commercial implantation of its HT Supreme drug-eluting […]
Ultromics’ EchoGo Core and EchoGo Pro platforms quickly deliver highly accurate assessments of heart function that support the diagnosis of coronary artery disease.
The Irvine, CA-based company said its ALIGN-AR pivotal trial will evaluate its Trilogy Heart Valve system.
Dive Brief: Abbott Laboratories received FDA approval for its Amplatzer Amulet left atrial appendage occluder device used […]
Memic is betting the small size of its device and potential to enable more hysterectomies to be done vaginally as differentiators that will enable it to grow sales to $136 million in 2025.
BrainQ, an Israeli stroke therapy technology company, closed a funding round worth $40 million. Hanaco […]
Memic Innovative Surgery is merging with MedTech Acquisition Corp. to go public.
The Xplore2/Pivotal study is for patients requiring right ventricular outflow tract (RVOT) reconstruction to correct certain congenital heart defects.
MedAlliance announced today that it closed patient enrollment for its clinical trial of the Selution SLR […]
Exactech this week announced that it has expanded its Truliant total knee system with a […]
Dive Brief: Almost two-third of manufacturers of novel technology devices plan to bring their products […]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.